Mosaic ImmunoEngineering (CPMV) Other Non-Current Assets (2011 - 2024)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other Non-Current Assets of $7000.0 for Q3 2024, down 96.48% quarter-over-quarter from $198887.0 in Q1 2019.
Mosaic ImmunoEngineering (CPMV) Other Non-Current Assets (2011 - 2024) Analysis & Trends
Mosaic ImmunoEngineering's Other Non-Current Assets history runs 8 years deep, the most recent figure standing at $7000.0 for Q3 2024.
- In Q3 2024, Other Non-Current Assets changed N/A year-over-year to $7000.0; the TTM figure through Sep 2024 stood at $7000.0 (changed N/A YoY), while the FY2018 annual figure was $21559.0, changed N/A from the prior year.
- Other Non-Current Assets for Q3 2024 stood at $7000.0, down from $198887.0 in the prior quarter.
- The five-year high for Other Non-Current Assets was $7000.0 in Q3 2024, with the low at $7000.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 618.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 109.58 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 65.13 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 202.31 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 104.44 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 62.96 Mn |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 7,000.00 |
| Feb 28, 2019 | 198,887.00 |
| May 31, 2018 | 21,559.00 |
| Nov 30, 2015 | 3,036.00 |
| Aug 31, 2015 | 3,036.00 |
| May 31, 2015 | 3,036.00 |
| Feb 28, 2015 | 9,969.00 |
| Nov 30, 2014 | 9,465.00 |
| Aug 31, 2014 | 3,036.00 |
| May 31, 2014 | 3,036.00 |
| Feb 28, 2014 | 3,036.00 |
| Nov 30, 2013 | 3,036.00 |
| Aug 31, 2013 | 70,358.00 |
| May 31, 2013 | 40,682.00 |
| Feb 28, 2013 | 2,010.00 |
| Nov 30, 2012 | 2,895.00 |
| Aug 31, 2012 | 2,017.00 |
| May 31, 2012 | 7,273.00 |
| Feb 29, 2012 | 27,955.00 |
| Nov 30, 2011 | 57,221.00 |